FBR Capital Raises Price Target on MasTec (MTZ) to $35 Following Strong 2Q
- Wall St lackluster ahead of Easter break, eyes sharp Q1 gains
- Home Depot agrees to buy SRS Distribution, sees TAM expanding to $1 trillion
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Stocks flat as strong quarter nears end; yen on intervention watch
- Dollar gains on euro with Fed's Waller hawkish on rates
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- Discover Financial Services (DFS) Announces CEO Resignation
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Timken (TKR) Appoints Tarak Mehta as New CEO
Notable 52-Week Highs and Lows 8/5: (MRK) (MTZ) (AZN) High; (CPSI) (BBRG) (APRI) Low
August 5, 2016 3:18 PM EDT52-Week High:Merck (NYSE: MRK) $62.98. Merck gaining as Bristol-Myers Squibb's CheckMate -026, phase 3 study of Opdivo for treatment of patients with NSCLC missed its primary endpoint.
Pre-Open Stock Movers 08/05: (RAX) (EGLT) (MRK) Higher; (HDP) (SWIR) (BMY) Lower (more...)
August 5, 2016 9:20 AM EDTToday's Pre-Open Stock Movers:
Hortonworks (NASDAQ: HDP) 32.9% LOWER; reported Q2 EPS of ($0.72), $0.02 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $43.6 million versus the consensus estimate of $45.26 million. GUIDANCE: Hortonworks sees Q3 2016 revenue of $45 million, versus the consensus of $49.3 million. Hortonworks sees FY2016 revenue of $177 million, versus the consensus of $191.4 million.
After-Hours Stock Movers 08/04: (EGLT) (RAX) (PCLN) Higher; (HDP) (SWIR) (FEYE) Lower (more...)
August 4, 2016 6:58 PM EDTToday's After-Hours Movers
Egalet Corporation (Nasdaq: EGLT) 31.2% HIGHER; announced that the joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 18 to 1 to recommend approval of ARYMO ER (morphine sulfate). ARYMO ER was developed using Egalet's proprietary Guardian Technology for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Hortonworks (NASDAQ:... More
MasTec (MTZ) Tops Q2 EPS by 13c, FY EPS Guidance Tops Views
August 4, 2016 5:20 PM EDTMasTec (NYSE: MTZ) reported Q2 EPS of $0.36, $0.13 better than the analyst estimate of $0.23. Revenue for the quarter came in at $1.23 billion versus the consensus estimate of $1.16 billion.
GUIDANCE:
MasTec sees FY2016 EPS of $1.57, versus the consensus of $1.41. MasTec sees FY2016... More